Application YC di Gamgee
San Francisco
Gamgee ha partecipato a Y Combinator nel batch Summer 2026 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Summer 2026
- Settore
- HealthcareDrug Discovery and Delivery
- Luogo
- San Francisco
- Dimensione team
- 2
- Stato
- Active
- Lanciata
- 2026
Founder
Paul ConynghamFounder/CEO
Cosa fa Gamgee
Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next
Application YC di Gamgee, ricostruita
Domanda per Y Combinator
Gamgee, batch Summer 2026. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Gamgee
Personalised mRNA cancer vaccines for dogs.
We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.
San Francisco, CA, USA; Remote. The company would remain based there after YC.
San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di Gamgee?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Gamgee (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Gamgee si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva Gamgee?
Gamgee apparteneva al batch Summer 2026 di Y Combinator.
Chi ha fondato Gamgee?
Gamgee è stato fondato da Paul Conyngham.
Cosa fa Gamgee?
Curing cancer. Starting with dogs.
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Gamgee, e di ogni altro batch YC, è in YC Insights.
Più startup YC come Gamgee
